These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Rasool N, Fader AN, Seamon L, Neubauer NL, Shahin FA, Alexander HA, Moore K, Moxley K, Secord AA, Kunos C, Rose PG, O'Malley DM. Gynecol Oncol; 2010 Jan; 116(1):10-4. PubMed ID: 19875158 [Abstract] [Full Text] [Related]
5. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens? Momeni M, Kolev V, Cardenas-Goicoechea J, Getrajdman J, Fishman D, Chuang L, Kalir T, Rahaman J, Zakashansky K. Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190 [Abstract] [Full Text] [Related]
6. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer. Alexander-Sefre F, Singh N, Ayhan A, Thomas JM, Jacobs IJ. Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262 [Abstract] [Full Text] [Related]
10. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG. Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [Abstract] [Full Text] [Related]